Director at $NVDA sells 3,590 shares, representing 0.2% of their shares

From Nasdaq: 2025-07-01 19:45:00

A director at $NVDA, A Brooke Seawell, sold 3,590 shares of the company for an estimated $552,772. This sale represented approximately 0.2% of their shares, leaving them with 1,604,274 shares. In the past 6 months, $NVDA insiders have made 0 purchases and 104 sales of stock.

Insiders like Mark A Stevens, Tench Coxe, and Jen Hsun Huang have been active in selling $NVDA stock. In the last 6 months, Mark A Stevens made 0 purchases and 5 sales, Tench Coxe sold 1,000,000 shares, and Jen Hsun Huang made 0 purchases and 32 sales, among others.

Institutional investors have also been active with $NVDA stock. Goldman Sachs Group Inc added 46,627,472 shares, while Capital International Investors added 36,523,224 shares. Price T Rowe Associates Inc removed 36,342,523 shares, and Bank of America Corp added 34,926,619 shares to their portfolios.

Members of Congress have traded $NVDA stock 53 times in the past 6 months, with 29 purchases and 24 sales. Representatives like Robert Bresnahan and Marjorie Taylor Greene have made multiple purchases, while others like Senator Sheldon Whitehouse have made sales.

Wall Street analysts have issued 14 buy ratings on $NVDA stock in recent months. Loop Capital Markets, Wedbush, and Benchmark are among the firms that have issued positive ratings. Analysts have set price targets with a median of $175.0, with targets ranging from $150.0 to $250.0.

Multiple analysts have set price targets for $NVDA, with a median target of $175.0. Loop Capital Markets, Morgan Stanley, and Piper Sandler are among the firms that have set price targets for the stock. It’s important to note that this article is not financial advice.



Read more at Nasdaq: Insider Sale: Director at $NVDA Sells 3,590 Shares